ArticleBMC infectious diseases2023

Treatment persistence of bictegravir/emtricitabine/tenofovir alafenamide and efavirenz + lamivudine + tenofovir disoproxil among HIV-1 patients newly starting treatment in Hunan Province in China.

Cao Jing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.